BRIEF-U.S. FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow

* U.S. FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow

The post BRIEF-U.S. FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow appeared first on NASDAQ.

Tags: